364 related articles for article (PubMed ID: 18265457)
1. [Methylprednisolone pulse therapy in Kawasaki disease].
Miura M; Matsuoka M; Kohno K; Ohki H; Yoshiba S
Nihon Rinsho; 2008 Feb; 66(2):338-42. PubMed ID: 18265457
[TBL] [Abstract][Full Text] [Related]
2. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
Furukawa T; Kishiro M; Akimoto K; Nagata S; Shimizu T; Yamashiro Y
Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
[TBL] [Abstract][Full Text] [Related]
3. [Steroid pulse therapy].
Miura M
Nihon Rinsho; 2014 Sep; 72(9):1631-5. PubMed ID: 25518414
[TBL] [Abstract][Full Text] [Related]
4. Effects of methylprednisolone pulse on cytokine levels in Kawasaki disease patients unresponsive to intravenous immunoglobulin.
Miura M; Kohno K; Ohki H; Yoshiba S; Sugaya A; Satoh M
Eur J Pediatr; 2008 Oct; 167(10):1119-23. PubMed ID: 18175148
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial.
Sundel RP; Baker AL; Fulton DR; Newburger JW
J Pediatr; 2003 Jun; 142(6):611-6. PubMed ID: 12838187
[TBL] [Abstract][Full Text] [Related]
6. The strategy of immune globulin resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy.
Ogata S; Bando Y; Kimura S; Ando H; Nakahata Y; Ogihara Y; Kaneko T; Minoura K; Kaida M; Yokota Y; Furukawa S; Ishii M
J Cardiol; 2009 Feb; 53(1):15-9. PubMed ID: 19167633
[TBL] [Abstract][Full Text] [Related]
7. Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial.
Ogata S; Ogihara Y; Honda T; Kon S; Akiyama K; Ishii M
Pediatrics; 2012 Jan; 129(1):e17-23. PubMed ID: 22144699
[TBL] [Abstract][Full Text] [Related]
8. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
Tse SM; Silverman ED; McCrindle BW; Yeung RS
J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
[TBL] [Abstract][Full Text] [Related]
9. Corticosteroid treatment of refractory Kawasaki disease.
Lang BA; Yeung RS; Oen KG; Malleson PN; Huber AM; Riley M; Ebbeson R; Ramsey SE; Laxer RM; Silverman ED; McCrindle BW; Ratnapalan S; Feldman BM
J Rheumatol; 2006 Apr; 33(4):803-9. PubMed ID: 16583481
[TBL] [Abstract][Full Text] [Related]
10. Management and outcome of intravenous gammaglobulin-resistant Kawasaki disease.
Sittiwangkul R; Pongprot Y; Silvilairat S; Phornphutkul C
Singapore Med J; 2006 Sep; 47(9):780-4. PubMed ID: 16924360
[TBL] [Abstract][Full Text] [Related]
11. Indirect-comparison meta-analysis of treatment options for patients with refractory Kawasaki disease.
Chan H; Chi H; You H; Wang M; Zhang G; Yang H; Li Q
BMC Pediatr; 2019 May; 19(1):158. PubMed ID: 31101091
[TBL] [Abstract][Full Text] [Related]
12. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM
Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
[TBL] [Abstract][Full Text] [Related]
13. Pulse methylprednisolone therapy in the treatment of immune globulin-resistant Kawasaki disease: case report and review of the literature.
Hung JJ; Chiu CH
Ann Trop Paediatr; 2004 Mar; 24(1):89-93. PubMed ID: 15005973
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of intravenous immunoglobulin combined with prednisolone following resistance to initial intravenous immunoglobulin treatment of acute Kawasaki disease.
Kobayashi T; Kobayashi T; Morikawa A; Ikeda K; Seki M; Shimoyama S; Ishii Y; Suzuki T; Nakajima K; Sakamoto N; Arakawa H
J Pediatr; 2013 Aug; 163(2):521-6. PubMed ID: 23485027
[TBL] [Abstract][Full Text] [Related]
15. Low-dose methotrexate therapy for intravenous immunoglobulin-resistant Kawasaki disease.
Lee TJ; Kim KH; Chun JK; Kim DS
Yonsei Med J; 2008 Oct; 49(5):714-8. PubMed ID: 18972590
[TBL] [Abstract][Full Text] [Related]
16. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy.
Hashino K; Ishii M; Iemura M; Akagi T; Kato H
Pediatr Int; 2001 Jun; 43(3):211-7. PubMed ID: 11380911
[TBL] [Abstract][Full Text] [Related]
17. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.
Uehara R; Belay ED; Maddox RA; Holman RC; Nakamura Y; Yashiro M; Oki I; Ogino H; Schonberger LB; Yanagawa H
Pediatr Infect Dis J; 2008 Feb; 27(2):155-60. PubMed ID: 18174868
[TBL] [Abstract][Full Text] [Related]
18. Methylprednisolone pulse therapy for massive lymphadenopathy in a child with intravenous immunoglobulin-resistant Kawasaki disease.
Chen HH; Liu PM; Bong CN; Wu YT; Yang KD; Wang CL
J Microbiol Immunol Infect; 2005 Apr; 38(2):149-52. PubMed ID: 15843862
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin.
Khowsathit P; Hong-Hgam C; Khositseth A; Wanitkun S
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1121-6. PubMed ID: 12549785
[TBL] [Abstract][Full Text] [Related]
20. [Effects of three intravenous gamma globulin regimens on Kawasaki disease and relevant coronary complication rates in pediatric patients: a comparative study].
DU ZD; Zhao D; DU JB; Lu S; Yi JM; Hou AC; Zhou ZS; Ding GF;
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3119-21. PubMed ID: 18269869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
